Program Committee

• Jeremy A. Abbate, Vice President & Publisher, Scientific American
• Querida Anderson, Editorial Director & Biopharma Expert 
• Phyllis Barkman Ferrell, Global Head of External Engagement for Alzheimer’s disease & Neurodegeneration, Eli Lilly & Company
• Derek Brand, Executive Director, Strategic Partnerships, Columbia Technology Ventures
• Sara Jane Demy, CEO & Founder, Demy-Colton
• Shira Derasmo, Founder, Cuttlefish Communications
• Walter Greenleaf, Distinguished Visiting Scholar, Stanford University’s MediaX Program
• Kimberly Ha, CEO & Founder, KKH Advisors
• Mark Kessel, Founding Advisor, Galileo Life Sciences
• Tim Opler, Managing Director, Stifel
• Art Pappas, Founder & Managing Partner, Pappas Capital
• Liz Powell, Founder, G2G Consulting
• Dennis Purcell, Founder & Senior Advisor, Aisling Capital
• Beth Rogozinski, CEO, Oncoustics
• Robert J. Schneider, Albert Sabin Professor of Molecular Pathogenesis, NYU School of Medicine
• Ajit Singh, Managing Director & General Partner, Artiman Ventures

BioFuture Advisory Board

• Laurence Blumberg, Lecturer, Weill Cornell Medicine
• Kimberly Ha, CEO & Founder, KKH Advisors
• Philippe Lopes-Fernandes, Executive Vice President, CBO, Ipsen
• Tim Opler, Managing Director, Stifel
• Art Pappas, Founder & Managing Partner, Pappas Capital
• Dennis Purcell, Founder & Senior Advisor, Aisling Capital
• Robert J. Schneider, Albert Sabin Professor of Molecular Pathogenesis, NYU School of Medicine